Details for Patent: 8,268,348
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Which drugs does patent 8,268,348 protect, and when does it expire?
Patent 8,268,348 protects ABRAXANE and is included in one NDA.
Protection for ABRAXANE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has one hundred and eighteen patent family members in twenty-six countries.
Summary for Patent: 8,268,348
| Title: | Combinations and modes of administration of therapeutic agents and combination therapy |
| Abstract: | The present invention provides combination therapy methods of treating proliferative diseases (such as cancer) comprising a first therapy comprising administering to an individual an effective amount of a taxane in a nanoparticle composition, and a second therapy which may include, for example, radiation, surgery, administration of chemotherapeutic agents, or combinations thereof. Also provided are methods of administering to an individual a drug taxane in a nanoparticle composition based on a metronomic dosing regime. |
| Inventor(s): | Desai; Neil P. (Los Angeles, CA), Soon-Shiong; Patrick (Los Angeles, CA) |
| Assignee: | Abraxis Bioscience, LLC (Los Angeles, CA) |
| Application Number: | 13/228,323 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,268,348 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 8,268,348
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol-myers | ABRAXANE | paclitaxel | POWDER;INTRAVENOUS | 021660-001 | Jan 7, 2005 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,268,348
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 531365 | ⤷ Sign Up | |||
| Australia | 2006213999 | ⤷ Sign Up | |||
| Australia | 2007317859 | ⤷ Sign Up | |||
| Brazil | PI0607809 | ⤷ Sign Up | |||
| Brazil | PI0718528 | ⤷ Sign Up | |||
| Canada | 2598239 | ⤷ Sign Up | |||
| Canada | 2668607 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
